Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.

Paclitaxel (Taxol)

Rowinsky, Eric K., Donehower, Ross C.·1995·New England Journal of Medicine

Abstract

The taxanes are an important new class of anticancer agents that exert their cytotoxic effects through a unique mechanism. Paclitaxel (Taxol), the first taxane in clinical trials, is active against a broad range of cancers that are generally considered to be refractory to conventional chemotherapy. This has led to the regulatory approval of paclitaxel in the United States and many other countries for use in the palliative therapy of patients with ovarian and breast cancers resistant to chemotherapy. The challenge now is to develop strategies using paclitaxel in the initial therapy of cancers in which cure or improved survival may . . .

Overview

Integrity signals

Registry

Crossref · 10.1056/nejm199504133321507

Cites

74 of 74 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 74 references

Research works printed but not linked: 47

  1. Burkhart CA, 1994, Cancer Res, 54, 5779
  2. Rowinsky EK, 1988, Cancer Res, 48, 4093
  3. Roberts JR, 1990, Cancer Res, 50, 710
  4. Rowinsky EK, 1989, Cancer Res, 49, 4640
  5. Tishler RB, 1992, Cancer Res, 52, 3495
  6. Horwitz SB, 1993, Monogr Natl Cancer Inst, 15, 55
  7. Grem JL, 1987, Cancer Treat Rep, 71, 1179
  8. Kris MG, 1986, Cancer Treat Rep, 70, 605
  9. Donehower RC, 1987, Cancer Treat Rep, 71, 1171
  10. Wiernik PH, 1987, Cancer Res, 47, 2486
  11. Ohnuma T, 1985, Proc Am Assoc Cancer Res, 26, 167
  12. Rowinsky EK, 1993, Semin Oncol, 20, 1
  13. Adams JD, 1993, Monogr Natl Cancer Inst, 15, 141
  14. Lassus M, 1985, Proc Am Soc Clin Oncol, 4, 268
  15. Rowinsky EK, 1993, Monogr Natl Cancer Inst, 15, 107
  16. Arbuck SG, 1993, Monogr Natl Cancer Inst, 15, 117
  17. Gianni L, 1994, Proc Am Soc Clin Oncol, 13, 74
  18. Kennedy MJ, 1994, Proc Am Soc Clin Oncol, 13, 137
  19. Longnecker SM, 1987, Cancer Treat Rep, 71, 53
  20. Rowinsky EK, 1993, Semin Oncol, 20, 16
  21. Schilder LE, 1994, Proc Am Soc Clin Oncol, 13, 136
  22. Monsarrat B, 1990, Drug Metab Dispos Biol Fate Chem, 18, 895
  23. Monsarrat B, 1993, Monogr Natl Cancer Inst, 15, 39
  24. Cresteil T, 1994, Cancer Res, 54, 386
  25. Harris JW, 1994, Cancer Res, 15, 4026
  26. Venook AP, 1994, Proc Am Soc Clin Oncol, 13, 139
  27. LeBlanc GA, 1992, Cancer Res, 52, 540
  28. McGuire WP, 1993, Proc Am Soc Clin Oncol, 12, 255
  29. Holmes FA, 1994, Ann Oncol, 5, 197
  30. Wiltshaw E, 1979, Cancer Treat Rep, 63, 1545
  31. McGuire WP. Paclitaxel in the treatment of ovarian cancer. In: Proceedings of the 30th Annual Meeting of the American Society of Clinical Oncology, Dallas, May 14–17, 1994. American Society of Clinical Oncology Educational Book. Chicago: American Society of Clinical Oncology, 1994:204-13.
  32. Seidman A, 1993, Proc Am Soc Clin Oncol, 12, 63
  33. Gelmon K, 1994, Ann Oncol, 5, 198
  34. Holmes FA, 1993, Proc Am Soc Clin Oncol, 12, 94
  35. Hudis C, 1994, Proc Am Soc Clin Oncol, 13, 65
  36. Ettinger DS, 1993, Proc Am Soc Clin Oncol, 12, 329
  37. Kirschling RJ, 1994, Proc Am Soc Clin Oncol, 13, 326
  38. Forastiere AA, 1993, Monogr Natl Cancer Inst, 15, 181
  39. 10.1002/1097-0142(19900601)65:11<2478::aid-cncr2820651114>3.0.co;2-s · DOI · Paper page
  40. 10.1002/1097-0142(19931015)72:8<2457::aid-cncr2820720825>3.0.co;2-z · doi:10.1002/1097-0142(19931015)72:8<2457::aid-cncr2820720825>3.0.co;2-z
  41. Einzig AI, 1993, Proc Am Soc Clin Oncol, 12, 194
  42. Brown T, 1993, Proc Am Soc Clin Oncol, 13, 200
  43. Rowinsky EK, 1992, Semin Oncol, 19, 646
  44. Roth BJ, 1994, Proc Am Soc Clin Oncol, 13, 230
  45. Bissery MC, 1991, Cancer Res, 51, 4845
  46. Trudeau ME, 1993, Proc Am Soc Clin Oncol, 12, 64
  47. De Forni M, 1994, Ann Oncol, 5, 202

Cited by

See all 1,924

Metadata

Authors
Rowinsky, E. K., & Donehower, R. C.
Affiliations
Johns Hopkins University (US)
Venue
New England Journal of Medicine
Published
1995-04-13
Volume
332
Issue
15
Pages
1004-1014
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W4255762755
Cited by
1,924
References
74
Citations by year
2026: 52 · 2025: 65 · 2024: 50 · 2023: 57 · 2022: 65 · 2021: 75 · 2020: 99 · 2019: 66 · 2018: 52 · 2017: 60 · 2016: 70 · 2015: 77 · 2014: 65 · 2013: 68 · 2012: 72
FWCI
5.29
Type
journal article
Language
en
Open access
closed
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Treatment and Pharmacology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords
paclitaxel, taxanes, anticancer agents, cytotoxicity mechanism, ovarian cancer, breast cancer, palliative care
MeSH terms
Arrhythmias, Cardiac, Breast Neoplasms, Drug Hypersensitivity, Female, Humans, Ovarian Neoplasms, Peripheral Nervous System Diseases, Paclitaxel

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Paclitaxel (Taxol). https://app.cochat.ai/papers/10.1056/nejm199504133321507
The paper
Rowinsky, E. K., & Donehower, R. C. (1995). Paclitaxel (Taxol). New England Journal of Medicine. https://doi.org/10.1056/nejm199504133321507

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.